|
|
||||||||



*
Departments of Pediatrics and Medicine, National Jewish Medical and Research Center, Denver, CO 80206;
Departments of Medicine and Immunology, University of Colorado Health Sciences Center, Denver, CO 80262;
Department of Immunology, Mayo Clinic and Mayo Graduate School of Medicine, Rochester, MN 55905;
§
Basel Institute for Immunology, Basel, Switzerland; and
¶
Department of Pathology, Centre Medical Universitaire, Geneva, Switzerland
Hybrids of New Zealand Black (NZB) and New Zealand White (NZW) mice spontaneously develop a disease similar to human systemic lupus erythematosus. MHC and non-MHC genes contribute to disease susceptibility in this murine model. Multiple studies have shown that the NZW H2z locus is strongly associated with the development of lupus-like disease in these mice. The susceptibility gene(s) within H2z is not known, but different lines of evidence have pointed to class II MHC genes, either H2-E or H2-A (Ez or Az in NZW). Recent studies from our laboratory showed that Ez does not supplant H2z in the contribution to lupus-like disease. In the present work we generated C57BL/10 (B10) mice transgenic for Aaz and Abz genes (designated B10.Az mice) and used a (B10.Az x NZB)F1 x NZB backcross to assess the contributions of Az genes to disease. A subset of backcross mice produced high levels of IgG autoantibodies and developed severe nephritis. However, no autoimmune phenotype was linked to the Az transgenes. Surprisingly, in the same backcross mice, inheritance of H2b from the nonautoimmune B10 strain was strongly linked with both autoantibody production and nephritis. Taken together with our previous Ez studies, the present work calls into question the importance of class II MHC genes for lupus susceptibility in this model and provides new insight into the role of MHC in lupus-like autoimmunity.
This article has been cited by other articles:
![]() |
S. C. Schweitzer, A. M. Reding, H. M. Patton, T. P. Sullivan, C. E. Stubbs, E. Villalobos-Menuey, S. A. Huber, and M. K. Newell Endogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression J. Lipid Res., November 1, 2006; 47(11): 2525 - 2537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Gubbels, T. N. Jorgensen, T. E. Metzger, K. Menze, H. Steele, S. A. Flannery, S. J. Rozzo, and B. L. Kotzin Effects of MHC and Gender on Lupus-Like Autoimmunity in Nba2 Congenic Mice J. Immunol., November 1, 2005; 175(9): 6190 - 6196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Subramanian, Y.-S. Yim, K. Liu, K. Tus, X. J. Zhou, and E. K. Wakeland Epistatic Suppression of Systemic Lupus Erythematosus: Fine Mapping of Sles1 to Less Than 1 Mb J. Immunol., July 15, 2005; 175(2): 1062 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Laporte, B. Ballester, C. Mary, S. Izui, and L. Reininger The Sgp3 Locus on Mouse Chromosome 13 Regulates Nephritogenic gp70 Autoantigen Expression and Predisposes to Autoimmunity J. Immunol., October 1, 2003; 171(7): 3872 - 3877. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. SM. Rahman, S.-K. Tin, P.-N. L. Buenaventura, C.-H. Ho, E. P. H. Yap, R. Y. Y. Yong, and D.-R. Koh A Novel Susceptibility Locus On Chromosome 2 in the (New Zealand Black x New Zealand White)F1 Hybrid Mouse Model of Systemic Lupus Erythematosus J. Immunol., March 15, 2002; 168(6): 3042 - 3049. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xie, S. Chang, P. Yang, C. Jacob, A. Kaliyaperumal, S. K. Datta, and C. Mohan Genetic Contributions of Nonautoimmune SWR Mice Toward Lupus Nephritis J. Immunol., December 15, 2001; 167(12): 7141 - 7149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. DUGUET, H. IIJIMA, S.-Y. EUM, Q. HAMID, and D. H. EIDELMAN Eosinophil Peroxidase Mediates Protein Nitration in Allergic Airway Inflammation in Mice Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1119 - 1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Paisansinsup, A. N. Vallejo, H. Luthra, and C. S. David HLA-DR Modulates Autoantibody Repertoire, But Not Mortality, in a Humanized Mouse Model of Systemic Lupus Erythematosus J. Immunol., October 1, 2001; 167(7): 4083 - 4090. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Tucker, T. J. Vyse, S. Rozzo, C. L. Roark, S. Izui, and B. L. Kotzin Genetic Control of Glycoprotein 70 Autoantigen Production and Its Influence on Immune Complex Levels and Nephritis in Murine Lupus J. Immunol., August 1, 2000; 165(3): 1665 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Rozzo, T. J. Vyse, K. Menze, S. Izui, and B. L. Kotzin Enhanced Susceptibility to Lupus Contributed from the Nonautoimmune C57BL/10, But Not C57BL/6, Genome J. Immunol., May 15, 2000; 164(10): 5515 - 5521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Stoll and J. Gavalchin Systemic lupus erythematosus--messages from experimental models Rheumatology, January 1, 2000; 39(1): 18 - 27. [Full Text] [PDF] |
||||
![]() |
T. J. Vyse, R. K. Halterman, S. J. Rozzo, S. Izui, and B. L. Kotzin Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus PNAS, July 6, 1999; 96(14): 8098 - 8103. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |